Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

Share Price is delayed by 15 minutes
Get Live Data
652.00    12.00 (1.88%)
Bid:
644.00
Ask:
660.00
Spread: 16.00 (2.484%)
Market Cap: £219.22m
AVG Live PriceLast checked at - London Stock Exchange

Intraday Avingtrans Share Chart

Board Appointment

19 Aug 2008 07:00

Embargoed Release: 07:00 hrs Tuesday 19 August 2008

Avingtrans Plc (`Avingtrans' or the `Group') Board Appointment and Board changes

Avingtrans Plc, the designer, manufacturer and supplier of critical components and associated services to the medical, energy, industrial and global aerospace sectors, is delighted to announce the appointment of Stephen ("Steve") McQuillan as chief executive officer. The Group believes the appointment of this highly regarded and experienced figure will bolster the strength of the management team as Avingtrans continues to exploit the excellent prospects in its respective markets going forward.

Steve McQuillan, age 47, will commence his duties as CEO from 1st October 2008. He brings extensive expertise to the Group from the engineering and technology sectors as he was previously managing director of Serco Defence Operations, a leading integrated service solutions provider to the worldwide defence and aerospace markets, from 2005 to 2008. Prior to this, Stephen was the managing director of Oxford Instruments Superconductivity Ltd, a subsidiary of Oxford Instruments plc, the designer, manufacturer and support services provider of high technology tools and systems for industry research, space, energy and healthcare sectors.

In conjunction with this appointment, Roger McDowell, who has been acting chief executive and non-executive chairman during the interim period, will revert to non-executive chairman as from 1st October 2008.

Roger McDowell commented:

"I very much welcome Stephen to the Board of Avingtrans as group chief executive; I am delighted that someone of such a high calibre with a wealth of UK and overseas experience has agreed to join the Group. Stephen has first class knowledge of and expertise in engineering, technology and knowledge transfer markets, which will be invaluable to the Group as we continue to expand our businesses."

Steve McQuillan commented:

"I am looking forward to working with the team at Avingtrans where I see significant opportunities to grow the businesses in its respective markets. The Group has strong technical and commercial capabilities and our aim will be to leverage these over the course of time."

-ENDS-

For further information, please contact:

Avingtrans plc

Roger McDowell, Non-Executive Chairman

Tel: 0115 949 9020

KBC Peel Hunt Ltd (Nominated Adviser & Broker)

Julian BluntDavid AndersonTel: 020 7418 8900Hansard Group Adam ReynoldsTel: 020 7245 1100

In accordance with paragraph (g) of Schedule 2 to the AIM Rules for Companies, the following information is provided:

Current Directorships Past Directorships over last 5 years NPL Management Limited Oxford Instruments Superconductivity Limited Airto Limited Oxford Instruments Superconductivity Holdings Limited Oxford Instruments Molecular Biotools Limited Resonance Instruments Limited

There is no further information in respect of the above appointment required to be disclosed pursuant to paragraph (g) of Schedule 2 to the AIM Rules for Companies.

vendor
Date   Source Headline
4th Apr 20171:32 pmRNSForm 8.5 (EPT/RI) Avingtrans PLC
4th Apr 201711:27 amRNSForm 8.5 (EPT/RI) Avingtrans PLC
3rd Apr 20174:27 pmRNSForm 8 (DD) - Avingtrans Plc
3rd Apr 20173:54 pmRNSForm 8.3 - Avingtrans Plc
3rd Apr 20172:34 pmRNSForm 8.5 (EPT/RI) Avingtrans PLC
3rd Apr 20179:30 amRNSForm 8.3 - [Avingtrans]
31st Mar 20173:51 pmPRNForm 8.3 - Avingtrans Plc
31st Mar 201712:10 pmRNSPotential Offer for Hayward Tyler Group plc
28th Feb 20177:00 amRNSInterim Results
28th Feb 20177:00 amRNSAcquisition of Superconducting Magnet Business
9th Jan 201712:45 pmRNSHolding(s) in Company
4th Jan 20173:54 pmRNSHolding(s) in Company
3rd Jan 201712:47 pmRNSHolding(s) in Company
22nd Dec 20166:25 pmRNSShare Incentive Awards Issue of Equity and TVR
21st Dec 20161:59 pmRNSShare Incentive Awards
13th Dec 20164:00 pmRNSExercise of Share Options
13th Dec 20162:15 pmRNSExercise of Share Options & PDMR Share Dealing
12th Dec 20164:30 pmRNSExercise of Share Options & PDMR Share Dealing
28th Nov 20161:07 pmRNSHolding(s) in Company
23rd Nov 20167:00 amRNSHolding(s) in Company
22nd Nov 20167:00 amRNSHolding(s) in Company
21st Nov 20167:00 amRNSChange of Nominated Advisor
18th Nov 20163:11 pmRNSHolding(s) in Company
18th Nov 20163:05 pmRNSTotal Voting Rights
8th Nov 201612:47 pmRNSResult of Tender Offer and Director's Interests
8th Nov 201612:46 pmRNSResult of AGM and GM
3rd Oct 20167:00 amRNSProposed Tender Offer and Notice of GM
29th Sep 20167:00 amRNSMetalcraft signs £9m contract
27th Sep 20167:00 amRNSAppointment of joint broker
27th Sep 20167:00 amRNSFinal Results
13th Sep 20164:00 pmRNSExercise of Share Options
7th Sep 20165:30 pmRNSExercise of Share Options
2nd Sep 201612:30 pmRNSExercise of Share Options
10th Aug 201610:10 amRNSHolding(s) in Company
2nd Aug 20167:00 amRNSMaloney Metalcraft signs £3.5m contract with EDF
12th Jul 20165:00 pmRNSHolding(s) in Company
4th Jul 20161:16 pmRNSExercise of Share Options
1st Jul 20162:18 pmRNSExercise of Share Options
30th Jun 20167:00 amRNSUpdate on Return of funds to Shareholders
21st Jun 20162:10 pmRNSHolding(s) in Company
1st Jun 20167:00 amRNSChange of Registered Office
31st May 20165:20 pmRNSExercise of Share Options - Correction
31st May 20165:10 pmRNSHolding(s) in Company
27th May 20162:07 pmRNSCompletion of Disposal
26th May 20161:53 pmRNSExercise of Share Options
25th May 201612:45 pmRNSResult of General Meeting
5th May 20167:00 amRNSHolding(s) in Company
4th May 20167:00 amRNSProposed Disposal and Notice of General Meeting
15th Mar 20168:25 amRNSExercise of Share Options
7th Mar 20167:00 amRNSSigma signs £75m deal with Rolls-Royce

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.